Literature DB >> 25833829

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Ester Bonastre1, Sara Verdura1, Ilse Zondervan2, Federica Facchinetti3, Sylvie Lantuejoul4, Maria Dolores Chiara5, Juan Pablo Rodrigo5, Julian Carretero6, Enric Condom7, Agustin Vidal7, David Sidransky8, Alberto Villanueva9, Luca Roz3, Elisabeth Brambilla4, Suvi Savola2, Montse Sanchez-Cespedes10.   

Abstract

Correct apicobasal polarization and intercellular adhesions are essential for the appropriate development of normal epithelia. Here, we investigated the contribution of the cell polarity regulator PARD3 to the development of lung squamous cell carcinomas (LSCC). Tumor-specific PARD3 alterations were found in 8% of LSCCs examined, placing PARD3 among the most common tumor suppressor genes in this malignancy. Most PAR3-mutant proteins exhibited a relative reduction in the ability to mediate formation of tight junctions and actin-based protrusions, bind atypical protein kinase C, activate RAC1, and activate STAT3 at cell confluence. Thus, PARD3 alterations prevented the formation of contacts between neighboring cells and the subsequent downstream signaling. Notably, reconstituting PAR3 activity in vivo reduced tumor-invasive and metastatic properties. Our findings define PARD3 as a recurrently inactivated cell polarity regulator in LSCC that affects tumor aggressiveness and metastasis. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833829      PMCID: PMC4612637          DOI: 10.1158/0008-5472.CAN-14-2444

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Self-association of PAR-3-mediated by the conserved N-terminal domain contributes to the development of epithelial tight junctions.

Authors:  Keiko Mizuno; Atsushi Suzuki; Tomonori Hirose; Koichi Kitamura; Koichi Kutsuzawa; Masaaki Futaki; Yoshiko Amano; Shigeo Ohno
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

2.  Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.

Authors:  Pedro P Medina; Octavio A Romero; Takashi Kohno; Luis M Montuenga; Ruben Pio; Jun Yokota; Montse Sanchez-Cespedes
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

3.  Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.

Authors:  Richard A Steinman; Abbey Wentzel; Yalin Lu; Christine Stehle; Jennifer Rubin Grandis
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

Review 4.  Lung cancer biology: a genetic and genomic perspective.

Authors:  M Sánchez-Céspedes
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

5.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

Authors:  Montserrat Sanchez-Cespedes; Paola Parrella; Manel Esteller; Shuji Nomoto; Barry Trink; James M Engles; William H Westra; James G Herman; David Sidransky
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

Review 6.  A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome.

Authors:  M Sanchez-Cespedes
Journal:  Oncogene       Date:  2007-06-18       Impact factor: 9.867

7.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

Review 8.  Par complex in cancer: a regulator of normal cell polarity joins the dark side.

Authors:  V Aranda; M E Nolan; S K Muthuswamy
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

9.  Rho-kinase phosphorylates PAR-3 and disrupts PAR complex formation.

Authors:  Masanori Nakayama; Takaaki M Goto; Masayuki Sugimoto; Takashi Nishimura; Takafumi Shinagawa; Sigeo Ohno; Mutsuki Amano; Kozo Kaibuchi
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

10.  A conserved oligomerization domain in drosophila Bazooka/PAR-3 is important for apical localization and epithelial polarity.

Authors:  Richard Benton; Daniel St Johnston
Journal:  Curr Biol       Date:  2003-08-05       Impact factor: 10.834

View more
  23 in total

1.  Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.

Authors:  Qiyuan Zhou; Jingbo Dai; Tianji Chen; Laura A Dada; Xu Zhang; Wei Zhang; Malcolm M DeCamp; Robert A Winn; Jacob I Sznajder; Guofei Zhou
Journal:  Cell Signal       Date:  2017-06-24       Impact factor: 4.315

2.  pETM: a penalized Exponential Tilt Model for analysis of correlated high-dimensional DNA methylation data.

Authors:  Hokeun Sun; Ya Wang; Yong Chen; Yun Li; Shuang Wang
Journal:  Bioinformatics       Date:  2017-06-15       Impact factor: 6.937

3.  RAS-mediated suppression of PAR3 and its effects on SCC initiation and tissue architecture occur independently of hyperplasia.

Authors:  Ji Ling; Maria Sckaff; Manisha Tiwari; Yifang Chen; Jingting Li; Jackson Jones; George L Sen
Journal:  J Cell Sci       Date:  2020-12-07       Impact factor: 5.285

4.  Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis.

Authors:  Shenyi Wang; Jinming Cai; Si Zhang; Mingwei Dong; Li Zhang; Yingying Xu; Bing Shen; She Chen
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

5.  Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.

Authors:  Hiroe Nakamura; Kazunori Nagasaka; Kei Kawana; Ayumi Taguchi; Yuriko Uehara; Mitsuyo Yoshida; Masakazu Sato; Haruka Nishida; Asaha Fujimoto; Tomoko Inoue; Katsuyuki Adachi; Takeshi Nagamatsu; Takahide Arimoto; Katsutoshi Oda; Yutaka Osuga; Tomoyuki Fujii
Journal:  BMC Cancer       Date:  2016-11-17       Impact factor: 4.430

Review 6.  Cell polarity signaling in the plasticity of cancer cell invasiveness.

Authors:  Aneta Gandalovičová; Tomáš Vomastek; Daniel Rosel; Jan Brábek
Journal:  Oncotarget       Date:  2016-05-03

7.  Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells.

Authors:  Ching-Yuan Wu; Jong-Yuh Cherng; Yao-Hsu Yang; Chun-Liang Lin; Feng-Che Kuan; Yin-Yin Lin; Yu-Shih Lin; Li-Hsin Shu; Yu-Ching Cheng; Hung Te Liu; Ming-Chu Lu; Jthau Lung; Pau-Chung Chen; Hui Kuan Lin; Kuan-Der Lee; Ying-Huang Tsai
Journal:  Oncotarget       Date:  2017-06-28

8.  Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.

Authors:  Yanara Marincevic-Zuniga; Johan Dahlberg; Sara Nilsson; Amanda Raine; Sara Nystedt; Carl Mårten Lindqvist; Eva C Berglund; Jonas Abrahamsson; Lucia Cavelier; Erik Forestier; Mats Heyman; Gudmar Lönnerholm; Jessica Nordlund; Ann-Christine Syvänen
Journal:  J Hematol Oncol       Date:  2017-08-14       Impact factor: 17.388

9.  High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.

Authors:  Songwei Li; Jian Huang; Fan Yang; Haiping Zeng; Yuyun Tong; Kejia Li
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

Review 10.  The polarity protein PARD3 and cancer.

Authors:  Farzaneh Atashrazm; Sarah Ellis
Journal:  Oncogene       Date:  2021-06-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.